PASG Financial Statements

Balance sheet, income statement, cash flow, and dividends for Passage Bio Inc (PASG).


$35.03M Market Cap.

As of 03/04/2025 5:00 PM ET (MRY) • Disclaimer

PASG Market Cap. (MRY)


PASG Shares Outstanding (MRY)


PASG Assets (MRY)


Total Assets

$102.41M

Total Liabilities

$41.15M

Total Investments

$39.18M

PASG Income (MRY)


Revenue

$0

Net Income

-$64.77M

Operating Expense

$64.77M

PASG Cash Flow (MRY)


CF Operations

-$47.96M

CF Investing

$54.95M

CF Financing

$8.87M

PASG Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PASG Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$102,412,000 (-31.97%)

$150,545,000 (-38.19%)

$243,549,000 (-31.41%)

$355,076,000 (8.25%)

Assets Current

$78,815,000 (-33.18%)

$117,959,000 (-40.14%)

$197,044,000 (-39.38%)

$325,066,000 (2.49%)

Assets Non-Current

$23,597,000 (-27.59%)

$32,586,000 (-29.93%)

$46,505,000 (54.97%)

$30,010,000 (177.25%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$61,261,000 (-44.95%)

$111,283,000 (-44.74%)

$201,366,000 (-36.81%)

$318,657,000 (4.58%)

Property Plant & Equipment Net

$23,134,000 (-28.05%)

$32,153,000 (-23.88%)

$42,238,000 (77.43%)

$23,806,000 (751.74%)

Cash & Equivalents

$37,573,000 (73.08%)

$21,709,000 (-37.26%)

$34,601,000 (-73.17%)

$128,965,000 (-4.47%)

Accumulated Other Comprehensive Income

$8,000 (118.60%)

-$43,000 (95.55%)

-$966,000 (-133.90%)

-$413,000 (-3341.67%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$39,183,000 (-57.68%)

$92,585,000 (-40.27%)

$155,009,000 (-17.02%)

$186,808,000 (10.01%)

Investments Current

$39,183,000 (-57.68%)

$92,585,000 (-40.27%)

$155,009,000 (-17.02%)

$186,808,000 (10.01%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$742,000 (-42.84%)

$1,298,000 (-68.07%)

$4,065,000 (-56.98%)

$9,448,000 (79.45%)

Accumulated Retained Earnings (Deficit)

-$659,235,000 (-10.89%)

-$594,468,000 (-20.73%)

-$492,406,000 (-38.21%)

-$356,281,000 (-108.48%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$25,476,000 (-3.11%)

$26,294,000 (-3.00%)

$27,107,000 (0%)

$0 (0%)

Debt Current

$3,688,000 (9.34%)

$3,373,000 (2.99%)

$3,275,000 (0%)

$0 (0%)

Debt Non-Current

$21,788,000 (-4.94%)

$22,921,000 (-3.82%)

$23,832,000 (0%)

$0 (0%)

Total Liabilities

$41,151,000 (4.81%)

$39,262,000 (-6.92%)

$42,183,000 (15.83%)

$36,419,000 (56.35%)

Liabilities Current

$19,363,000 (18.49%)

$16,341,000 (-10.95%)

$18,351,000 (-37.79%)

$29,498,000 (39.31%)

Liabilities Non-Current

$21,788,000 (-4.94%)

$22,921,000 (-3.82%)

$23,832,000 (244.34%)

$6,921,000 (226.77%)

PASG Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$24,988,000 (-39.90%)

$41,580,000 (-15.73%)

$49,341,000 (-17.84%)

$60,056,000 (99.43%)

Research & Development Expense

$40,179,000 (-34.58%)

$61,419,000 (-28.63%)

$86,053,000 (-26.87%)

$117,673,000 (43.88%)

Operating Expenses

$64,767,000 (-36.54%)

$102,062,000 (-26.25%)

$138,394,000 (-25.49%)

$185,729,000 (64.50%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$64,767,000 (36.54%)

-$102,062,000 (25.02%)

-$136,125,000 (26.57%)

-$185,386,000 (-65.18%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$64,767,000 (36.54%)

-$102,062,000 (25.02%)

-$136,125,000 (26.57%)

-$185,386,000 (-65.18%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$64,767,000 (36.54%)

-$102,062,000 (25.02%)

-$136,125,000 (26.57%)

-$185,386,000 (-65.18%)

Weighted Average Shares

$60,405,036 (10.34%)

$54,743,490 (0.58%)

$54,429,023 (2.03%)

$53,343,959 (38.14%)

Weighted Average Shares Diluted

$60,405,036 (10.34%)

$54,743,490 (0.58%)

$54,429,023 (2.03%)

$53,343,959 (38.14%)

Earning Before Interest & Taxes (EBIT)

-$64,767,000 (36.54%)

-$102,062,000 (25.02%)

-$136,125,000 (26.57%)

-$185,386,000 (-65.18%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$64,767,000 (36.54%)

-$102,062,000 (26.25%)

-$138,394,000 (25.49%)

-$185,729,000 (-64.50%)

PASG Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$54,946,000 (-15.77%)

$65,237,000 (158.89%)

$25,199,000 (155.00%)

-$45,814,000 (73.38%)

Net Cash Flow from Financing

$8,874,000 (6473.33%)

$135,000 (109.98%)

-$1,353,000 (-100.81%)

$166,656,000 (-27.15%)

Net Cash Flow from Operations

-$47,956,000 (38.73%)

-$78,264,000 (33.79%)

-$118,210,000 (6.83%)

-$126,879,000 (-57.57%)

Net Cash Flow / Change in Cash & Cash Equivalents

$15,864,000 (223.05%)

-$12,892,000 (86.34%)

-$94,364,000 (-1463.09%)

-$6,037,000 (74.71%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$54,980,000 (-15.91%)

$65,383,000 (114.56%)

$30,473,000 (251.07%)

-$20,172,000 (88.17%)

Capital Expenditure

-$34,000 (76.71%)

-$146,000 (97.23%)

-$5,274,000 (79.43%)

-$25,642,000 (-1457.84%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$1,786,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$8,874,000 (6473.33%)

$135,000 (-68.82%)

$433,000 (-99.74%)

$166,994,000 (-27.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,820,000 (-46.71%)

$10,921,000 (-42.38%)

$18,954,000 (-42.02%)

$32,691,000 (124.22%)

Depreciation Amortization & Accretion

$3,081,000 (-17.20%)

$3,721,000 (1.14%)

$3,679,000 (138.43%)

$1,543,000 (92.88%)

PASG Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-78.60% (-7.52%)

-73.10% (-28.25%)

-57.00% (-17.28%)

-48.60% (-50.93%)

Return on Average Assets (ROAA)

-54.00% (3.91%)

-56.20% (-18.32%)

-47.50% (-5.79%)

-44.90% (-45.78%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-66.20% (-3.92%)

-63.70% (-1.92%)

-62.50% (33.30%)

-93.70% (28.69%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.53 (2.39%)

-0.54 (1.63%)

-0.55 (69.75%)

-1.82 (79.23%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.57 (14.86%)

0.5 (33.16%)

0.37 (-65.31%)

1.08 (-71.79%)

Debt to Equity Ratio (D/E)

0.67 (90.37%)

0.35 (68.90%)

0.21 (83.33%)

0.11 (50.00%)

Earnings Per Share (EPS)

-1.07 (42.47%)

-1.86 (25.60%)

-2.5 (28.16%)

-3.48 (-19.59%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.79 (44.55%)

-1.43 (36.89%)

-2.27 (20.64%)

-2.86 (-34.35%)

Book Value Per Share (BVPS)

1.01 (-50.12%)

2.03 (-45.05%)

3.7 (-38.06%)

5.97 (-24.29%)

Tangible Assets Book Value Per Share (TABVPS)

1.7 (-38.36%)

2.75 (-38.55%)

4.47 (-32.77%)

6.66 (-21.64%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-1 (88.89%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.46 (5.70%)

-0.49 (-62.58%)

-0.3 (69.28%)

-0.98 (88.63%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

4.07 (-43.62%)

7.22 (-32.77%)

10.74 (-2.56%)

11.02 (-26.43%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$47,990,000 (38.80%)

-$78,410,000 (36.50%)

-$123,484,000 (19.04%)

-$152,521,000 (-85.63%)

Enterprise Value (EV)

$28,554,228 (-40.89%)

$48,306,834 (20.75%)

$40,004,503 (-77.86%)

$180,688,885 (-81.25%)

Earnings Before Tax (EBT)

-$64,767,000 (36.54%)

-$102,062,000 (25.02%)

-$136,125,000 (26.57%)

-$185,386,000 (-65.18%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$61,686,000 (37.27%)

-$98,341,000 (25.75%)

-$132,446,000 (27.96%)

-$183,843,000 (-64.98%)

Invested Capital

$70,952,000 (-48.88%)

$138,789,000 (-36.25%)

$217,704,000 (10.73%)

$196,613,000 (14.42%)

Working Capital

$59,452,000 (-41.49%)

$101,618,000 (-43.13%)

$178,693,000 (-39.54%)

$295,568,000 (-0.15%)

Tangible Asset Value

$102,412,000 (-31.97%)

$150,545,000 (-38.19%)

$243,549,000 (-31.41%)

$355,076,000 (8.25%)

Market Capitalization

$35,028,228 (-36.74%)

$55,367,834 (-26.45%)

$75,283,503 (-78.09%)

$343,578,885 (-70.49%)

Average Equity

$82,354,250 (-41.00%)

$139,581,000 (-41.54%)

$238,779,750 (-37.36%)

$381,164,250 (9.40%)

Average Assets

$120,021,750 (-33.94%)

$181,685,000 (-36.60%)

$286,560,250 (-30.56%)

$412,678,500 (13.28%)

Invested Capital Average

$97,765,500 (-38.99%)

$160,256,500 (-26.42%)

$217,789,750 (10.08%)

$197,853,750 (131.57%)

Shares

61,767,286 (12.67%)

54,819,638 (0.49%)

54,553,263 (0.82%)

54,106,911 (18.83%)